The Canadian federal government has extended funding for research into rare diseases, according to a meeting of Canadian health ministers. The decision follows a previous agreement that was set to expire. The extension aims to support ongoing studies and treatments for conditions that affect fewer than 1 in 2,000 people.
The funding deal was confirmed during a meeting of health ministers, though details on the exact amount and duration of the extension were not disclosed. The move comes as broader discussions on overall health-care funding remain unresolved. Health officials emphasized the importance of continued investment in rare disease research, which often lacks sufficient public funding.
This extension marks the second time the federal government has renewed support for rare disease research. Previous funding was criticized for being insufficient to meet the needs of patients and researchers. The current agreement is expected to provide stability for ongoing projects, but experts say more long-term funding is needed to make significant breakthroughs. The government has not yet announced plans for future funding increases or policy changes related to rare diseases.
